FORM 10-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

May 22, 2019

Period of Report

February 28, 2019

Accession Number

0001144204-19-027771

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →